IDEXX Laboratories, Inc. (IDXX | DoD: +1.12% | YTD: +29.75% | LargeCap: 42.2B)

• Profile: A global leader in pet healthcare innovation
• Reporting: IDEXX Laboratories to Release 2025 Second Quarter Financial Results (Full Text)

IceCure Medical Ltd (ICCM | DoD: +7.59% | YTD: -19.52% | SmallCap: 59M)

• Profile: Developer of a liquid nitrogen-based system for freezing and destroying benign and cancerous tumors in the breast, kidney, lung and other areas
• Stock Offering: IceCure Announces Record Date for Rights Offering for Up to $10 Million (Full Text)

Innovative Eyewear, Inc. (LUCY | DoD: -9.64% | YTD: -58.26% | SmallCap: 10M)

• Profile: The developer of smart eyewear under the Lucyd¬Æ, Nautica¬Æ, Eddie Bauer ¬Æ and Reebok¬Æ brands
• Financing: Innovative Eyewear, Inc. Announces Closing of Exercise of Warrants (Full Text)

Lifeward Ltd. (LFWD | DoD: +3.12% | YTD: -56.54% | SmallCap: 13M)

• Profile: Maker of industry-leading personal exoskeleton for persons with spinal cord injury
• Stock Offering: Lifeward Announces Pricing of $2.6 Million Public Offering (Full Text)

Femasys Inc. (FEMY | DoD: -1.78% | YTD: -19.55% | SmallCap: 22M)

• Profile: A leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products
• Regulatory: Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control (Full Text)

GeneDx Holdings Corp. (WGS | DoD: +14.04% | YTD: +14.15% | MidCap: 2.1B)

• Profile: Maker of industry-leading exome and genome tests that translate complex genomic data into clinical answers
• Clinical: GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics (Full Text)

GlucoTrack, Inc. (GCTK | DoD: -0.48% | YTD: -98.37% | SmallCap: 4M)

• Profile: A medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes
• Clinical: Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions (Full Text)

InspireMD, Inc. (NSPR | DoD: -1.79% | YTD: -6.95% | SmallCap: 78M)

• Profile: Developer of the CGuard‚Ñ¢ Prime carotid stent system for the prevention of stroke
• FDA Clearance: InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke (Full Text)

Lifeward Ltd. (LFWD | DoD: +3.12% | YTD: -56.54% | SmallCap: 13M)

• Profile: Maker of industry-leading personal exoskeleton for persons with spinal cord injury
• Regulatory: Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary (Full Text)

Stryker Corporation (SYK | DoD: +1.93% | YTD: +7.98% | LargeCap: 144.9B)

• Profile: A global leader in medical technologies
• FDA Clearance: Stryker receives FDA clearance for Incompass Total Ankle System (Full Text)

Tivic Health Systems, Inc. (TIVC | DoD: +1.29% | YTD: -32.77% | SmallCap: 3M)

• Profile: A health tech company, develops and commercializes bioelectronic medicine
• Clinical: Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device (Full Text)

908 Devices Inc. (MASS | DoD: -0.30% | YTD: +202.28% | SmallCap: 227M)

• Profile: A commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets
• Partnership: Asylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500 (Full Text)

Alcon Inc. (ALC | DoD: +2.18% | YTD: +4.91% | LargeCap: 42.1B)

• Profile: The global leader in eye care dedicated to helping people see brilliantly
• Product: Gordon Schanzlin New Vision Institute Becomes First U.S. Clinic to Use Alcon's Breakthrough Unity Phaco System (Full Text)

INVO Fertility, Inc. (IVF | DoD: -6.54% | YTD: -90.08% | SmallCap: 3M)

• Profile: Focuses on the fertility marketplace that provides assisted reproductive technology care to patients
• Patent: INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent (Full Text)

Intelligent Bio Solutions Inc. (INBS | DoD: -2.73% | YTD: +26.24% | SmallCap: 10M)

• Profile: A medical technology company, developing rapid, non-invasive testing, and screening solutions
• Partnership: Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia (Full Text)

Koninklijke Philips N.V. (PHG | DoD: +5.38% | YTD: -0.82% | MidCap: 21.1B)

• Profile: A leading health technology company focused on improving people‚Äôs health and well-being through meaningful innovation
• Partnership: Methodist Hospitals Selects Philips to Advance Neurovascular, Cardiology and Complex Interventional Radiology Services in Northwest Indiana (Full Text)

Mainz Biomed N.V. (MYNZ | DoD: +2.88% | YTD: -66.74% | SmallCap: 8M)

• Profile: Develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer
• Product: Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test (Full Text)

ReShape Lifesciences Inc. (RSLS | DoD: +2.34% | YTD: -97.70% | SmallCap: 3M)

• Profile: Provides products and services that manage and treat obesity and metabolic diseases
• Patent: ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology (Full Text)

Glaukos Corporation (GKOS | DoD: +3.51% | YTD: -33.06% | MidCap: 5.4B)

• Profile: An ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases
• Event: Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell (Full Text)

OPKO Health, Inc. (OPK | DoD: +1.57% | YTD: -11.03% | MidCap: 1.1B)

• Profile: A multinational biopharmaceutical and diagnostics company
• Event: OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium (Full Text)

Quest Diagnostics Incorporated (DGX | DoD: +0.10% | YTD: +20.34% | MidCap: 19.3B)

• Profile: A leading provider of diagnostic information services
• Report: Quest Diagnostics Releases 2024 Corporate Responsibility Report (Full Text)

NeuroPace, Inc. (NPCE | DoD: +1.80% | YTD: -7.08% | SmallCap: 428M)

• Profile: Founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders
• Leadership Update: NeuroPace Announces Strategic CFO Transition (Full Text)

STAAR Surgical Company (STAA | DoD: +3.00% | YTD: -28.71% | SmallCap: 858M)

• Profile: The global leader in vision correction technology
• Leadership Update: STAAR Surgical Announces Appointment of Deborah Andrews as Chief Financial Officer, Forms Capital Stewardship Committee of the Board of Directors (Full Text)